Hundreds of the top oncologists and cancer researchers have conducted interviews with OncLive, which has contributed to a library of thousands of videos. To browse these interviews by the oncologist's names, click here >>>
Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL).
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now